Xylem Inc. (XYL) earnings date, results and what the price requires
NYSE · SEC CIK 0001524472 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 28, 2026 | $2.34B | $263.0M | $1.11 | Filing |
| Mar 31, 2026 | Apr 28, 2026 | $2.13B | $193.0M | $0.79 | Filing |
| Dec 31, 2025 | Feb 10, 2026 | $2.40B | $335.0M | $1.37 | Filing |
| Sep 30, 2025 | Oct 28, 2025 | $2.27B | $227.0M | $0.93 | Filing |
| Jun 30, 2025 | Jul 31, 2025 | $2.30B | $226.0M | $0.93 | Filing |
| Mar 31, 2025 | Apr 29, 2025 | $2.07B | $169.0M | $0.69 | Filing |
| Dec 31, 2024 | Jan 30, 2025 | $2.26B | $326.0M | $1.33 | Filing |
| Sep 30, 2024 | Oct 31, 2024 | $2.10B | $217.0M | $0.89 | Filing |
What would Xylem Inc. have to report for its valuation to change?
At $104.05, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 16.2% a year, to $8.89. On that path the next quarter needs diluted EPS near $1.08, against $0.93 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 16.2% | 16.2% |
| EPS needed in final year | $8.89 | $8.89 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. XYL goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.